History of IVD ELISA test development for peripheral neuropathies by BÜHLMANN - BÜHLMANN has a long and very successful history in the neuroimmunology field, specifically by offering unique high quality diagnostic tests for peripheral neuropathies. Learn more about the history of clinically relevant anti-ganglioside antibodies and the development of IVD ELISA tests for neuropathies by BÜHLMANN.
Quantum Blue® Anti-Infliximab (CE marked) available now for clinical routine use! - BÜHLMANN is pleased to announce the addition of Quantum Blue® Anti-Infliximab (CE IVD) to the therapeutic drug monitoring rapid test portfolio.
Video Interview about the newly available External Quality Assessment (EQA) Scheme for the Basophil Activation Test (BAT) - We had the opportunity to talk to Prof. Dr. Ulrich Sack, Head of the Immune Diagnostics, Institute of Immunology, University Hospital Leipzig about the introduction of the External Quality Assessment (EQA) scheme for the Basophil Activation Test (BAT) in the field of allergy.

Deutscher Rheumatologiekongress 2020

Date: 9 – 12 September 2020
Location: virtual event

48. Kongress der Deutschen Gesellschaft für Rheumatologie e.V.

Deutscher Allergiekongress 2020

Date: 24 – 26 September 2020
Location: Wiesbaden, Germany

15. Deutscher Allergiekongress

ÖCCO Symposium 2020

Date: 2 – 3 October 2020
Location: Bad Ischl, Austria

5. Österreichisches Crohn Colitis Symposium


Date: 6 – 8 October 2020
Location: virtual event 

52° Congresso Nazionale SIBioC – Medicina di Laboratorio